Israel’s Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2025.

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has ...